866-997-4948(US-Canada Toll Free)

Global Retinal Drugs and Biologics Sales Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 119 Pages

In this report, the global Retinal Drugs and Biologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Retinal Drugs and Biologics for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Retinal Drugs and Biologics market competition by top manufacturers/players, with Retinal Drugs and Biologics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Alimera Sciences
Janssen Biotech
F. Hoffmann-La Roche Ltd
Genzyme Corporation
Ocular Therapeutix
UCBCares
Allergan
AbbVie Inc
Swedish Orphan Biovitrum
Bristol-Myers Squibb Company
Genentech USA
Bausch & Lomb Incorporated
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Surgery
Medicines
Retinal Laser
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Retinal Drugs and Biologics for each application, including
Hospital Pharmacies
Retail Pharmacies
Specialty Ophthalmology Clinics
Others
Table of Contents

Global Retinal Drugs and Biologics Sales Market Report 2017
1 Retinal Drugs and Biologics Market Overview
1.1 Product Overview and Scope of Retinal Drugs and Biologics
1.2 Classification of Retinal Drugs and Biologics by Product Category
1.2.1 Global Retinal Drugs and Biologics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Retinal Drugs and Biologics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Surgery
1.2.4 Medicines
1.2.5 Retinal Laser
1.2.6 Others
1.3 Global Retinal Drugs and Biologics Market by Application/End Users
1.3.1 Global Retinal Drugs and Biologics Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Specialty Ophthalmology Clinics
1.3.5 Others
1.4 Global Retinal Drugs and Biologics Market by Region
1.4.1 Global Retinal Drugs and Biologics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.4.3 China Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.4.4 Europe Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.4.5 Japan Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.4.6 Southeast Asia Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.4.7 India Retinal Drugs and Biologics Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Retinal Drugs and Biologics (2012-2022)
1.5.1 Global Retinal Drugs and Biologics Sales and Growth Rate (2012-2022)
1.5.2 Global Retinal Drugs and Biologics Revenue and Growth Rate (2012-2022)

2 Global Retinal Drugs and Biologics Competition by Players/Suppliers, Type and Application
2.1 Global Retinal Drugs and Biologics Market Competition by Players/Suppliers
2.1.1 Global Retinal Drugs and Biologics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Retinal Drugs and Biologics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Retinal Drugs and Biologics (Volume and Value) by Type
2.2.1 Global Retinal Drugs and Biologics Sales and Market Share by Type (2012-2017)
2.2.2 Global Retinal Drugs and Biologics Revenue and Market Share by Type (2012-2017)
2.3 Global Retinal Drugs and Biologics (Volume and Value) by Region
2.3.1 Global Retinal Drugs and Biologics Sales and Market Share by Region (2012-2017)
2.3.2 Global Retinal Drugs and Biologics Revenue and Market Share by Region (2012-2017)
2.4 Global Retinal Drugs and Biologics (Volume) by Application

3 United States Retinal Drugs and Biologics (Volume, Value and Sales Price)
3.1 United States Retinal Drugs and Biologics Sales and Value (2012-2017)
3.1.1 United States Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
3.1.2 United States Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
3.1.3 United States Retinal Drugs and Biologics Sales Price Trend (2012-2017)
3.2 United States Retinal Drugs and Biologics Sales Volume and Market Share by Players
3.3 United States Retinal Drugs and Biologics Sales Volume and Market Share by Type
3.4 United States Retinal Drugs and Biologics Sales Volume and Market Share by Application

4 China Retinal Drugs and Biologics (Volume, Value and Sales Price)
4.1 China Retinal Drugs and Biologics Sales and Value (2012-2017)
4.1.1 China Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
4.1.2 China Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
4.1.3 China Retinal Drugs and Biologics Sales Price Trend (2012-2017)
4.2 China Retinal Drugs and Biologics Sales Volume and Market Share by Players
4.3 China Retinal Drugs and Biologics Sales Volume and Market Share by Type
4.4 China Retinal Drugs and Biologics Sales Volume and Market Share by Application

5 Europe Retinal Drugs and Biologics (Volume, Value and Sales Price)
5.1 Europe Retinal Drugs and Biologics Sales and Value (2012-2017)
5.1.1 Europe Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
5.1.2 Europe Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
5.1.3 Europe Retinal Drugs and Biologics Sales Price Trend (2012-2017)
5.2 Europe Retinal Drugs and Biologics Sales Volume and Market Share by Players
5.3 Europe Retinal Drugs and Biologics Sales Volume and Market Share by Type
5.4 Europe Retinal Drugs and Biologics Sales Volume and Market Share by Application

6 Japan Retinal Drugs and Biologics (Volume, Value and Sales Price)
6.1 Japan Retinal Drugs and Biologics Sales and Value (2012-2017)
6.1.1 Japan Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
6.1.2 Japan Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
6.1.3 Japan Retinal Drugs and Biologics Sales Price Trend (2012-2017)
6.2 Japan Retinal Drugs and Biologics Sales Volume and Market Share by Players
6.3 Japan Retinal Drugs and Biologics Sales Volume and Market Share by Type
6.4 Japan Retinal Drugs and Biologics Sales Volume and Market Share by Application

7 Southeast Asia Retinal Drugs and Biologics (Volume, Value and Sales Price)
7.1 Southeast Asia Retinal Drugs and Biologics Sales and Value (2012-2017)
7.1.1 Southeast Asia Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Retinal Drugs and Biologics Sales Price Trend (2012-2017)
7.2 Southeast Asia Retinal Drugs and Biologics Sales Volume and Market Share by Players
7.3 Southeast Asia Retinal Drugs and Biologics Sales Volume and Market Share by Type
7.4 Southeast Asia Retinal Drugs and Biologics Sales Volume and Market Share by Application

8 India Retinal Drugs and Biologics (Volume, Value and Sales Price)
8.1 India Retinal Drugs and Biologics Sales and Value (2012-2017)
8.1.1 India Retinal Drugs and Biologics Sales and Growth Rate (2012-2017)
8.1.2 India Retinal Drugs and Biologics Revenue and Growth Rate (2012-2017)
8.1.3 India Retinal Drugs and Biologics Sales Price Trend (2012-2017)
8.2 India Retinal Drugs and Biologics Sales Volume and Market Share by Players
8.3 India Retinal Drugs and Biologics Sales Volume and Market Share by Type
8.4 India Retinal Drugs and Biologics Sales Volume and Market Share by Application

9 Global Retinal Drugs and Biologics Players/Suppliers Profiles and Sales Data
9.1 Alimera Sciences
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Alimera Sciences Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Janssen Biotech
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Janssen Biotech Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 F. Hoffmann-La Roche Ltd
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Genzyme Corporation
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Genzyme Corporation Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Ocular Therapeutix
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Ocular Therapeutix Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 UCBCares
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 UCBCares Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Allergan
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Allergan Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 AbbVie Inc
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 AbbVie Inc Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Swedish Orphan Biovitrum
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Bristol-Myers Squibb Company
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Retinal Drugs and Biologics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Genentech USA
9.12 Bausch & Lomb Incorporated

10 Retinal Drugs and Biologics Maufacturing Cost Analysis
10.1 Retinal Drugs and Biologics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Retinal Drugs and Biologics
10.3 Manufacturing Process Analysis of Retinal Drugs and Biologics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Retinal Drugs and Biologics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Retinal Drugs and Biologics Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Retinal Drugs and Biologics Market Forecast (2017-2022)
14.1 Global Retinal Drugs and Biologics Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Retinal Drugs and Biologics Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Retinal Drugs and Biologics Price and Trend Forecast (2017-2022)
14.2 Global Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Retinal Drugs and Biologics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Retinal Drugs and Biologics Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Retinal Drugs and Biologics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Retinal Drugs and Biologics Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Retinal Drugs and Biologics Sales Forecast by Type (2017-2022)
14.3.2 Global Retinal Drugs and Biologics Revenue Forecast by Type (2017-2022)
14.3.3 Global Retinal Drugs and Biologics Price Forecast by Type (2017-2022)
14.4 Global Retinal Drugs and Biologics Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Table

List of Tables and Figures

Figure Product Picture of Retinal Drugs and Biologics
Figure Global Retinal Drugs and Biologics Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Retinal Drugs and Biologics Sales Volume Market Share by Type (Product Category) in 2016
Figure Surgery Product Picture
Figure Medicines Product Picture
Figure Retinal Laser Product Picture
Figure Others Product Picture
Figure Global Retinal Drugs and Biologics Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Retinal Drugs and Biologics by Application in 2016
Figure Hospital Pharmacies Examples
Figure Retail Pharmacies Examples
Figure Specialty Ophthalmology Clinics Examples
Figure Others Examples
Figure Global Retinal Drugs and Biologics Market Size (Million USD) by Regions (2012-2022)
Figure United States Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Retinal Drugs and Biologics Sales Volume (K Units) (2012-2017)
Table Global Retinal Drugs and Biologics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Retinal Drugs and Biologics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure 2017 Retinal Drugs and Biologics Sales Share by Players/Suppliers
Figure Global Retinal Drugs and Biologics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Retinal Drugs and Biologics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Retinal Drugs and Biologics Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Retinal Drugs and Biologics Revenue Share by Players
Table 2017 Global Retinal Drugs and Biologics Revenue Share by Players
Table Global Retinal Drugs and Biologics Sales (K Units) and Market Share by Type (2012-2017)
Table Global Retinal Drugs and Biologics Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Type (2012-2017)
Figure Global Retinal Drugs and Biologics Sales Growth Rate by Type (2012-2017)
Table Global Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Retinal Drugs and Biologics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Type (2012-2017)
Figure Global Retinal Drugs and Biologics Revenue Growth Rate by Type (2012-2017)
Table Global Retinal Drugs and Biologics Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Retinal Drugs and Biologics Sales Share by Region (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure Global Retinal Drugs and Biologics Sales Growth Rate by Region in 2016
Table Global Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Retinal Drugs and Biologics Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure Global Retinal Drugs and Biologics Revenue Growth Rate by Region in 2016
Table Global Retinal Drugs and Biologics Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Retinal Drugs and Biologics Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Retinal Drugs and Biologics by Region (2012-2017)
Figure Global Retinal Drugs and Biologics Revenue Market Share by Region in 2016
Table Global Retinal Drugs and Biologics Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Retinal Drugs and Biologics Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Retinal Drugs and Biologics by Application (2012-2017)
Figure Global Retinal Drugs and Biologics Sales Market Share by Application (2012-2017)
Figure United States Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure United States Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table United States Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table United States Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure United States Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table United States Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table United States Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure United States Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table United States Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table United States Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure United States Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure China Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure China Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table China Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table China Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table China Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure China Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Europe Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table Europe Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table Europe Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Europe Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Europe Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table Europe Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Europe Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Japan Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table Japan Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Japan Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table Japan Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Japan Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure Southeast Asia Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Figure India Retinal Drugs and Biologics Sales (K Units) and Growth Rate (2012-2017)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Retinal Drugs and Biologics Sales Price (USD/Unit) Trend (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume (K Units) by Players (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume Market Share by Players (2012-2017)
Figure India Retinal Drugs and Biologics Sales Volume Market Share by Players in 2016
Table India Retinal Drugs and Biologics Sales Volume (K Units) by Type (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume Market Share by Type (2012-2017)
Figure India Retinal Drugs and Biologics Sales Volume Market Share by Type in 2016
Table India Retinal Drugs and Biologics Sales Volume (K Units) by Application (2012-2017)
Table India Retinal Drugs and Biologics Sales Volume Market Share by Application (2012-2017)
Figure India Retinal Drugs and Biologics Sales Volume Market Share by Application in 2016
Table Alimera Sciences Basic Information List
Table Alimera Sciences Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Alimera Sciences Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Alimera Sciences Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Janssen Biotech Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Janssen Biotech Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd Basic Information List
Table F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Ltd Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Genzyme Corporation Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Genzyme Corporation Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Ocular Therapeutix Basic Information List
Table Ocular Therapeutix Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Ocular Therapeutix Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Ocular Therapeutix Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table UCBCares Basic Information List
Table UCBCares Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure UCBCares Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure UCBCares Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Allergan Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Allergan Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table AbbVie Inc Basic Information List
Table AbbVie Inc Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure AbbVie Inc Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure AbbVie Inc Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Swedish Orphan Biovitrum Basic Information List
Table Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Swedish Orphan Biovitrum Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Sales Global Market Share (2012-2017
Figure Bristol-Myers Squibb Company Retinal Drugs and Biologics Revenue Global Market Share (2012-2017)
Table Genentech USA Basic Information List
Table Bausch & Lomb Incorporated Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Retinal Drugs and Biologics
Figure Manufacturing Process Analysis of Retinal Drugs and Biologics
Figure Retinal Drugs and Biologics Industrial Chain Analysis
Table Raw Materials Sources of Retinal Drugs and Biologics Major Players in 2016
Table Major Buyers of Retinal Drugs and Biologics
Table Distributors/Traders List
Figure Global Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Retinal Drugs and Biologics Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Retinal Drugs and Biologics Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Retinal Drugs and Biologics Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Retinal Drugs and Biologics Sales Volume Market Share Forecast by Regions in 2022
Table Global Retinal Drugs and Biologics Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Retinal Drugs and Biologics Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Retinal Drugs and Biologics Revenue Market Share Forecast by Regions in 2022
Figure United States Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Retinal Drugs and Biologics Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Retinal Drugs and Biologics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Retinal Drugs and Biologics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Retinal Drugs and Biologics Sales (K Units) Forecast by Type (2017-2022)
Figure Global Retinal Drugs and Biologics Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Retinal Drugs and Biologics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Retinal Drugs and Biologics Revenue Market Share Forecast by Type (2017-2022)
Table Global Retinal Drugs and Biologics Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Retinal Drugs and Biologics Sales (K Units) Forecast by Application (2017-2022)
Figure Global Retinal Drugs and Biologics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *